Evonik Health Care
Birmingham, AL · Vancouver, BC
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
81.4
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
✓ MHRA GMP (2)
Quick Facts: Evonik Health Care
- Signal Score
- 81.4/100 (as of 2026-04-29)
- Quality Compliance
- 99.6/100
- Headquarters
- Birmingham, AL · Vancouver, BC
- Modalities
- mRNA, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Evonik Health Care
LNP formulation and drug delivery CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.6
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-09-11)
MHRA GMP Certificates2 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Evonik Industries (EVK.DE)
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Evonik Industries (EVK.DE)
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Birmingham, AL, Vancouver, BC
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
Recent Press2 articles
2 manufacturing sites
FDA Inspection History
2025-09
2024-12
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-09-11 | Lafayette, Indiana | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2024-12-10 | Birmingham, Alabama | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved May 20, 2026
FDA 483 Findings 1 observations · 2025-11-07 → 2025-11-07 ?
By subsystem
By severity
- 2 — Minor: 1
- Repeat observations: 0
Most severe findings
-
Pest control
"You did not exclude pests from your food plant to protect against contamination of food."
MHRA GMP Compliance 2 certificates
2016-05
2016-05
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK GMP 36752 Insp GMP 36752/7750465-0002 [H] | EVONIK CORPORATION | 35211 | 2016-05-09 | COMPLIANT |
| UK GMP 36752 Insp GMP 36752/7750465-0002 [V] | EVONIK CORPORATION | 35211 | 2016-05-09 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved May 20, 2026
Recent News 2 articles
Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia - ChemAnalyst
Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia ChemAnalyst
Evonik expands biotechnology capabilities in Slovakia - The Chemical Engineer
Evonik expands biotechnology capabilities in Slovakia The Chemical Engineer
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
mRNA, Plasmid, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics